This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Eli Lilly and Company, The Hospital for Sick Children, Other. Active years: 1980-2019.
Company Filing History:
1 out of 4,508 
1 out of 167 
1 out of 834,411 Years Active: 1980-2019
Title: Charles M Deber: Innovator in Antimicrobial Peptides and Membrane Proteins
Introduction
Charles M Deber is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of antimicrobial peptides and molecular weight markers for membrane proteins. With a total of 3 patents, his work has the potential to impact various medical applications.
Latest Patents
One of Deber's latest patents focuses on cationic antimicrobial peptides. This invention outlines a method for treating infections by administering a peptide in synergistic combination with an antibiotic. The peptide comprises an amino acid sequence with specific formulas that enhance its effectiveness. Another significant patent involves molecular weight markers for membrane proteins, providing a novel approach to identifying and characterizing these essential biological components.
Career Highlights
Throughout his career, Charles M Deber has worked with prominent organizations, including Eli Lilly and Company. His research has contributed to advancements in understanding and treating infections, showcasing his commitment to improving healthcare outcomes.
Collaborations
Deber has collaborated with talented individuals such as Arianna Rath and Vincent G Nadeau. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Charles M Deber's contributions to the field of biomedical research through his patents on antimicrobial peptides and membrane protein markers highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and research methodologies.